From DCAT Value Chain Insights (VCI)
Camagro Pharmaceutical Services has appointed Steven A. Castillo as vice president of drug development. Camagro specializes in product development for the 505(b)(2) process from concept through commercialization.
He has more than 25 years of research and global drug development experience. Before joining Camargo, Castillo was a biotechnology consultant. His program management expertise includes clinical operations, clinical pharmacology, medical affairs, biostatistics, pharmacovigilance, legal, finance, business development, and executive management.
Source: Camagro Pharmaceutical Services
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription